MedPath

Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia

Recruiting
Conditions
Hereditary Hemorrhagic Telangiectasia
Registration Number
NCT04469517
Lead Sponsor
University Hospital, Essen
Brief Summary

Patients with hereditary hemorrhagic telangiectasia (HHT) suffer from an inherited disorder leading to systemic vascular malformations. Mutations in several genes of the transforming growth factor (TGF)-β superfamily pathway influence angiogenesis in patients with HHT. The genetic loss of ALK1 or ENG alone are not sufficient to induce AVMs; environmental insults that could trigger angiogenesis (e.g. wounding) are also needed. In this study it will be analyzed if hypoxic induced factors could have an influence on the disease HHT.

Detailed Description

Hereditary hemorrhagic telangiectasia (HHT) is characterized by systemic vascular malformations leading to recurrent bleedings and shunt formation especially in the liver, lungs and the brain. The underlying pathogenic HHT mechanism remains unclear. The wide variability in age of onset and severity of symptoms amongst patients, even within the same family, suggests several factors contribute to the complexity of this disease. Mutations in several genes of the transforming growth factor (TGF)-β superfamily pathway influence angiogenesis in patients with HHT. The genetic loss of ALK1 or ENG alone are not sufficient to induce AVMs; environmental insults that could trigger angiogenesis (e.g. wounding) are also needed. In this study it will be analyzed if hypoxic induced factors could have an influence on the disease HHT.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • diagnosed HHT (genetic testing and/ or fulfill at least 3 Curacao Criteria)
  • older than 17 years
  • ability to consent
Exclusion Criteria
  • if inclusion Criteria are not met

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differences in hypoxic induced factors12 months

Differences in hypoxic induced factors analyzed in blood samples from patients with HHT and healthy controls

Secondary Outcome Measures
NameTimeMethod
Correlation of level of hypoxic induced factors and disease severity12 months

Correlation of level of hypoxic induced factors in patients' blood sample and their disease severity

Trial Locations

Locations (1)

University Hospital Essen

🇩🇪

Essen, NRW, Germany

University Hospital Essen
🇩🇪Essen, NRW, Germany
Freya Droege, MD
Contact
0049201723
freya.droege@uk-essen.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.